Literature DB >> 1098499

Amodiaquine resistant falciparum malaria in Thailand.

A P Hall, H E Segal, E J Pearlman, P Phintuyothin, S Kosakal.   

Abstract

Amodiaquine cured 38% (13/34) of patients with falciparum malaria in Southeast Thailand. Chloroquine cured 0% (0/13). The cure rates with amodiaquine were the same whether a 1.5 g or 2.0 g course was used. Most patients were resistant to amodiaquine at the RI level and to chloroquine at the RII level. In hospital, amodiaquine cleared parasitemia more frequently than did chloroquine. With the 2.0 g course of amodiaquine, the parasite clearance time was 77 hours; the fever clearance time of 36 hours was low and suggests that amodiaquine does not cause a drug fever. Because of resistance, chloroquine should not be used for falciparum malaria in Thailand. Routine use of amodiaquine is not indicated because more effective drugs are available.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1098499     DOI: 10.4269/ajtmh.1975.24.575

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  5 in total

1.  Geographic patterns of Plasmodium falciparum drug resistance distinguished by differential responses to amodiaquine and chloroquine.

Authors:  Juliana Martha Sá; Olivia Twu; Karen Hayton; Sahily Reyes; Michael P Fay; Pascal Ringwald; Thomas E Wellems
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-02       Impact factor: 11.205

Review 2.  Treatment of malaria--1990.

Authors:  D M Panisko; J S Keystone
Journal:  Drugs       Date:  1990-02       Impact factor: 9.546

3.  Polymorphisms of molecular markers of antimalarial drug resistance and relationship with artesunate-mefloquine combination therapy in patients with uncomplicated Plasmodium falciparum malaria in Thailand.

Authors:  Poonuch Muhamad; Papichaya Phompradit; Wannapa Sornjai; Thunyaluk Maensathian; Wanna Chaijaroenkul; Ronnatrai Rueangweerayut; Kesara Na-Bangchang
Journal:  Am J Trop Med Hyg       Date:  2011-09       Impact factor: 2.345

4.  Activities of various 4-aminoquinolines against infections with chloroquine-resistant strains of Plasmodium falciparum.

Authors:  L H Schmidt; D Vaughan; D Mueller; R Crosby; R Hamilton
Journal:  Antimicrob Agents Chemother       Date:  1977-05       Impact factor: 5.191

Review 5.  The threat of antimalarial drug resistance.

Authors:  Borimas Hanboonkunupakarn; Nicholas J White
Journal:  Trop Dis Travel Med Vaccines       Date:  2016-07-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.